Expression of drug resistance related proteins in sarcomas of the pulmonary artery and poorly differentiated leiomyosarcomas of other origin

[1]  L. Medeiros,et al.  DNA Topoisomerase IIα in Multiple Myeloma: A Marker of Cell Proliferation and Not Drug Resistance , 2001, Modern Pathology.

[2]  A. Gaumann,et al.  Intrinsic Expression of Drug Resistance-Associated Factors in Meningiomas , 2001, Applied immunohistochemistry & molecular morphology : AIMM.

[3]  Diponkar Banerjee,et al.  Metallothionein expression in patients with small cell carcinoma of the lung , 2001, Cancer.

[4]  S. Garrett,et al.  Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis. , 2001, The American journal of pathology.

[5]  P. Petrow,et al.  Osteopontin expression in primary sarcomas of the pulmonary artery , 2001, Virchows Archiv.

[6]  A. Gaumann,et al.  Drug Resistance-associated Factors in Primary and Secondary Glioblastomas and their Precursor Tumors , 2000, Journal of Neuro-Oncology.

[7]  Rebecca Lynn Johnson,et al.  Topoisomerase IIα Expression in Breast Cancer: Correlation with Outcome Variables , 2000, Modern Pathology.

[8]  M. Welters,et al.  Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines. , 1998, British Journal of Cancer.

[9]  A. Wittmann,et al.  Is the expression of multidrug resistance gene product a prognostic indicator for the clinical outcome of patients with renal cancer? , 1997, British journal of urology.

[10]  T. Ishida,et al.  Overexpression of resistance‐related proteins (metallothioneins, glutathione‐S‐transferase π, heat shock protein 27, and lung resistance‐related protein) in osteosarcoma , 1997, Cancer.

[11]  Y. Rustum,et al.  MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. , 1996, The American journal of pathology.

[12]  S. de Jong,et al.  Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review). , 1996, Anticancer research.

[13]  R. Pirker,et al.  Clinical relevance of drug resistance genes in malignant disease. , 1996, Leukemia.

[14]  Paul J Thornalley.  Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy. , 1996, General pharmacology.

[15]  G. Giaccone,et al.  Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. , 1996, The American journal of pathology.

[16]  R. Shoemaker,et al.  Overlapping phenotypes of multidrug resistance among panels of human cancer‐cell lines , 1996, International journal of cancer.

[17]  H. Clevers,et al.  The drug resistance-related protein LRP is the human major vault protein , 1995, Nature Medicine.

[18]  J. Kummermehr,et al.  Quantitative distinction of cisplatin-sensitive and -resistant mouse fibrosarcoma cells grown in multicell tumor spheroids. , 1995, Cancer research.

[19]  G. M. Wilson,et al.  Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.

[20]  P. Iversen,et al.  Metallothionein in carcinogenesis and cancer chemotherapy. , 1994, General pharmacology.

[21]  F. Baas,et al.  The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[23]  R. Livingston,et al.  Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells. , 1993, Cancer research.

[24]  M. Slovak,et al.  Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. , 1993, Cancer research.

[25]  R. Kerbel,et al.  Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. , 1992, Cancer research.

[26]  H. Takano,et al.  DNA topoisomerase-targeting antitumor agents and drug resistance. , 1992, Anti-cancer drugs.

[27]  H. Mogami,et al.  T98G glioma cells have nicks in DNA in quiescent phase. , 1990, Experimental cell research.

[28]  M. Melamed,et al.  Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[29]  W. Payne,et al.  Primary pulmonary artery sarcoma. A method of resection. , 1990, Chest.

[30]  L. Rome,et al.  Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes , 1990, The Journal of cell biology.

[31]  M. Mattern,et al.  Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors. , 1989, Journal of the National Cancer Institute.

[32]  Y. Nakanuma,et al.  PRIMARY PULMONARY ARTERY SARCOMA. Report of Two Autopsy Cases Studied by Immunohistochemistry and Electron Microscopy, and Review of 110 Cases Reported in the Literature , 1988, Acta pathologica japonica.

[33]  P. Schein,et al.  Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Bakka,et al.  Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein. , 1983, Cancer research.

[35]  K. Becker,et al.  The multidrug-resistance gene MDR1 is expressed in human glial tumors , 2004, Acta Neuropathologica.

[36]  K. Kasai,et al.  The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat heart and lung during endotoxin shock , 2004, Virchows Archiv.

[37]  H. Kauczor,et al.  Surgical treatment of pulmonary artery sarcoma. , 2001, The Journal of thoracic and cardiovascular surgery.

[38]  Y. Oshika,et al.  Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts. , 1997, British Journal of Cancer.

[39]  J. Endicott,et al.  The biochemistry of P-glycoprotein-mediated multidrug resistance. , 1989, Annual review of biochemistry.